HADDIE FLORES: Open Payments
NPI 1457902728 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,070 in 26 payments from 10 companies in 2025. Trend: 2023 $849 · 2024 $1,094 · 2025 $1,070
Food & beverage: $1,070
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $299 |
| SANOFI-AVENTIS U.S. LLC | 4 | $198 |
| Janssen Biotech, Inc. | 6 | $151 |
| BeiGene USA, Inc. | 2 | $150 |
| BeOne Medicines USA, Inc. | 3 | $72 |
| GENZYME CORPORATION | 2 | $68 |
| Legend Biotech USA Inc. | 2 | $67 |
| Adaptive Biotechnologies Corporation | 1 | $24 |
| Blueprint Medicines Corporation | 1 | $23 |
| Incyte Corporation | 1 | $17 |
Products named: CALQUENCE, BRUKINSA, REZUROCK, DARZALEX, CARVYKTI, SARCLISA, ENHERTU, clonoSEQ.
Industry payments across FL — which companies pay providers there.
